Long‐term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort study

2021 ◽  
Author(s):  
Mehak Pahwa ◽  
Boney Joseph ◽  
Nicolas A. Nunez ◽  
Gregory D. Jenkins ◽  
Colin L. Colby ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Bipolar Disorder ◽  
Cohort Study ◽  
Kidney Disease ◽  
Lithium Therapy ◽  
Historical Cohort ◽  
Historical Cohort Study

Detecting high-risk chronic kidney disease–mineral bone disorder phenotypes among patients on dialysis: a historical cohort study

2018 ◽  
Vol 34 (4) ◽  
pp. 682-691 ◽  
Author(s):  
Luca Neri ◽  
Ursula Kreuzberg ◽  
Francesco Bellocchio ◽  
Diego Brancaccio ◽  
Carlo Barbieri ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Cohort Study ◽  
High Risk ◽  
Kidney Disease ◽  
Historical Cohort ◽  
Historical Cohort Study ◽  
Mineral Bone Disorder ◽  
Bone Disorder

Correlations between dental assistance/oral health and clinical intercurrences in an end-stage kidney disease patients: a historical cohort study

2020 ◽  
Vol 69 (2) ◽  
Author(s):  
Sandra M. Assante ◽  
Susana Morimoto ◽  
Tamara K. Tedesco ◽  
Thais Gimenez ◽  
Karen M. Ramalho
Keyword(s):  
Cohort Study ◽  
Oral Health ◽  
Kidney Disease ◽  
End Stage Kidney Disease ◽  
Historical Cohort ◽  
Historical Cohort Study ◽  
End Stage

Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients

2021 ◽  
Author(s):  
Emanuele Durante-Mangoni ◽  
Giuseppe Giuffrè ◽  
Maria Paola Ursi ◽  
Domenico Iossa ◽  
Lorenzo Bertolino ◽  
...  
Keyword(s):  
Cohort Study ◽  
Infective Endocarditis ◽  
Historical Cohort ◽  
Historical Cohort Study ◽  
Long Term Mortality

Long-term socio-economic consequences and health care costs of poliomyelitis: a historical cohort study involving 3606 polio patients

2016 ◽  
Vol 263 (6) ◽  
pp. 1120-1128 ◽  
Author(s):  
Nete Munk Nielsen ◽  
Lise Kay ◽  
Benedikte Wanscher ◽  
Rikke Ibsen ◽  
Jakob Kjellberg ◽  
...  
Keyword(s):  
Health Care ◽  
Cohort Study ◽  
Health Care Costs ◽  
Economic Consequences ◽  
Historical Cohort ◽  
Historical Cohort Study ◽  
Care Costs

The risk of chronic kidney disease among women with polycystic ovary syndrome: A long‐term population‐based cohort study

2020 ◽  
Vol 93 (5) ◽  
pp. 590-597
Author(s):  
Samira Behboudi‐Gandevani ◽  
Mina Amiri ◽  
Leila Cheraghi ◽  
Saber Amanollahi Soudmand ◽  
Fereidoun Azizi ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Cohort Study ◽  
Kidney Disease ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Population Based ◽  
Ovary Syndrome

scholarly journals Migraine and subsequent chronic kidney disease risk: a nationwide population-based cohort study

BMJ Open ◽  
2017 ◽  
Vol 7 (12) ◽  
pp. e018483 ◽  
Author(s):  
Shuo-Chun Weng ◽  
Chia-Lin Wu ◽  
Chew-Teng Kor ◽  
Ping-Fang Chiu ◽  
Ming-Ju Wu ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Cohort Study ◽  
Kidney Disease ◽  
Disease Risk ◽  
Population Based ◽  
Interactive Effects ◽  
Control Group ◽  
Research Database ◽  
Control Subjects

ObjectiveWe compared the incidence and risk of chronic kidney disease (CKD) between subjects with new-onset migraine and matched controls without migraine in this large-scale retrospective cohort study.DesignPopulation-based cohort study.Setting8880 subjects with migraine and 503 070 subjects without migraine were enrolled between January 1, 2000 and December 31, 2013, all diagnosed to be without kidney disease. All the participants were registered in the National Health Insurance Research Database.ParticipantsFinally, data from 7156 subjects with migraine and 7156 propensity-score-matched control subjects were analysed.Primary outcome measureWe used Cox proportional hazards regression to estimate adjusted HRs for incident CKD; subgroup analyses were performed to assess the interactive effects of migraine with demographics, comorbidities and long-term medications.ResultsThe incidence of CKD was higher in the migraine group than in the control group. The risk of developing CKD was significantly higher in subjects with migraine than without migraine (P=0.031). Subjects with migraine aged <65 years (age 40–64 (adjusted HR (aHR) 1.35; 95% CI 1.05 to 1.73); age <40 (aHR 1.55; 95% CI 1.02 to 2.36)), with ≥1 comorbid diseases (1–2 diseases (aHR 1.30; 95% CI 1.01 to 1.68); ≥3 diseases (aHR 1.45; 95% CI 1.01 to 2.07)), and not receiving anti-migraine agents (aHR 1.26; 95% CI 1.04 to 1.54) were at a higher risk of developing CKD compared with the control subjects. The interaction between migraine and comorbidities was not significant; age, male gender and long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) were independent risk factors for CKD in subjects with migraine.ConclusionMigraine may be an independent risk factor for CKD. Young subjects with migraine, and those with comorbid conditions or without medical control, are likely to be at higher risk for CKD. Ageing, male sex and NSAIDs tend to have an association with CKD in subjects with migraine.

Sign in / Sign up

Export Citation Format

Share Document